Pharmacokinetics of inhaled pyrene in rats.
Male Wistar rats were exposed to micronized aerosol concentrations of a 14C-labeled model polycyclic aromatic hydrocarbon (pyrene) at 200, 500, and 800 mg/m3 for a period of 95 min. Both the 14C label and free pyrene were monitored in the blood, urine, and feces. At the termination of the blood sampling, three of the six rats per dose group were killed and the distribution of [14C]pyrene to eight major tissues was analyzed. The analysis of blood concentration data using a one-compartment pharmacokinetic model revealed that the uptake and elimination kinetic parameters were dose dependent, for both total radioactivity (pyrene plus metabolites) and for pyrene per se, over the range of exposures used in this study. The ratio of the percent excreted via the urinary and fecal routes, collected over a 5-d period postexposure was about 1.0 at each exposure level.
Withey
J R
JR
Environmental Health Center, Environmental and Occupational Toxicology Division, Tunney's Pasture, Ottawa, Ontario, Canada.
Burnett
R
R
Law
F C
FC
Abedini
S
S
Endrenyi
L
L
D000042:Absorption; D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D008297:Male; D008954:Models, Biological; D011721:Pyrenes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar; D012044:Regression Analysis; D014018:Tissue Distribution
D000336:Aerosols; D011721:Pyrenes; C030984:pyrene